https://scholars.lib.ntu.edu.tw/handle/123456789/594886
標題: | Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study | 作者: | Zucali P.A. CHIA-CHI LIN Carthon B.C. Bauer T.M. Tucci M. Italiano A. Iacovelli R. Su W.-C. Massard C. Saleh M. Daniele G. Greystoke A. Gutierrez M. Pant S. YING-CHUN SHEN Perrino M. Meng R. Abbadessa G. Lee H. Dong Y. Chiron M. Wang R. Loumagne L. L?pine L. De Bono J. |
公開日期: | 2022 | 出版社: | BMJ Publishing Group | 卷: | 10 | 期: | 1 | 來源出版物: | Journal for ImmunoTherapy of Cancer | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123747016&doi=10.1136%2fjitc-2021-003697&partnerID=40&md5=a7fcbe94e10fac056b7ff30c633645d3 https://scholars.lib.ntu.edu.tw/handle/123456789/594886 |
ISSN: | 2051-1426 | DOI: | 10.1136/jitc-2021-003697 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。